Pradeep Suryawanshi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pradeep Suryawanshi has a total of 142 co-authors. Here are the top co-authors by number of shared publications:
Sujata Deshpande
Department of Neonatology, Bharati Vidyapeeth Deemed University Medical College and Hospital
15 shared publicationsReema Garegrat
Centre for Perinatal Neuroscience, Clinical research fellow, Imperial College, London, England
11 shared publicationsRema Nagpal
Department of Neonatology, Bharati Vidyapeeth Deemed University Medical College and Hospital, Pune, India
10 shared publicationsAditya Kallimath
Department of Neonatology, Bharati Vidyapeeth (Deemed to be University) Medical College, Pune, India
9 shared publicationsPari Singh
Department of Neonatology, Bharati Vidyapeeth Deemed University Medical College and Hospital
9 shared publicationsChinmay Chetan
Department of Neonatology, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, India
8 shared publications
Latest Publications
- Open Access
- 3 September 2026
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 14, 1880755
Clinical utility of renal and urinary tract point-of-care ultrasound in the neonatal intensive care unit: insights from a case series
Background: Clinical decision-making in acutely ill neonates often depends on the timely identification of the underlying pathology. Bedside point-of-care ultrasound (POCUS), performed by the treating clinician, allows immediate correlation of imaging findings with evolving clinical status. However, its role in evaluating renal and urinary tract abnormalities in neonates remains relatively underexplored and is not yet widely integrated into routine practice. Methods: This multicenter case series included data from four tertiary neonatal intensive care units in India between January 2023 and March 2026. Neonates with acute clinical presentations in whom clinician-performed POCUS identified significant renal, adrenal, or urinary tract abnormalities were included. Ultrasound findings were interpreted alongside clinical and laboratory data and corroborated with formal imaging where required. Results: Seven neonates with diverse clinical presentations were evaluated. POCUS identified a spectrum of infective, obstructive, hemorrhagic, and vascular pathologies involving the kidneys, bladder, and adrenal glands. Early detection with POCUS informed timely therapeutic decisions, including initiation of targeted antimicrobial or antifungal therapy, anticoagulation, relief of urinary obstruction, and appropriate conservative management. Serial examinations enabled ongoing assessment of disease evolution and response to treatment. Conclusion: Clinician-performed renal and urinary tract POCUS provides actionable diagnostic information in acutely ill neonates and supports prompt, targeted management at the bedside. Its use may enhance clinical decision-making, particularly in time-sensitive situations where immediate access to comprehensive imaging is limited. These findings support incorporation of renal–urinary tract POCUS into structured neonatal POCUS training programs.
- 3 September 2026
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 14, 1880755
Open AccessClinical utility of renal and urinary tract point-of-care ultrasound in the neonatal intensive care unit: insights from a case series
Background: Clinical decision-making in acutely ill neonates often depends on the timely identification of the underlying pathology. Bedside point-of-care ultrasound (POCUS), performed by the treating clinician, allows immediate correlation of imaging findings with evolving clinical status. However, its role in evaluating renal and urinary tract abnormalities in neonates remains relatively underexplored and is not yet widely integrated into routine practice. Methods: This multicenter case series included data from four tertiary neonatal intensive care units in India between January 2023 and March 2026. Neonates with acute clinical presentations in whom clinician-performed POCUS identified significant renal, adrenal, or urinary tract abnormalities were included. Ultrasound findings were interpreted alongside clinical and laboratory data and corroborated with formal imaging where required. Results: Seven neonates with diverse clinical presentations were evaluated. POCUS identified a spectrum of infective, obstructive, hemorrhagic, and vascular pathologies involving the kidneys, bladder, and adrenal glands. Early detection with POCUS informed timely therapeutic decisions, including initiation of targeted antimicrobial or antifungal therapy, anticoagulation, relief of urinary obstruction, and appropriate conservative management. Serial examinations enabled ongoing assessment of disease evolution and response to treatment. Conclusion: Clinician-performed renal and urinary tract POCUS provides actionable diagnostic information in acutely ill neonates and supports prompt, targeted management at the bedside. Its use may enhance clinical decision-making, particularly in time-sensitive situations where immediate access to comprehensive imaging is limited. These findings support incorporation of renal–urinary tract POCUS into structured neonatal POCUS training programs.
- Open Access
- 25 August 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (17) , 2712
Lung Ultrasound-Guided Non-Fiberobronchoscopic Bronchoalveolar Lavage for Neonatal Atelectatic Pulmonary Disease Treatment: Clinical Practice Guidelines Based on International Expert Consensus
Severe pulmonary diseases, including atelectasis, pneumonia, and meconium aspiration syndrome, are major causes of neonatal respiratory distress, weaning difficulties, ventilator or oxygen dependence, prolonged oxygen requirements, extended hospitalization, and poor prognosis. The lack of simple and effective treatment strategies seriously endangers the survival and health of newborns, particularly premature infants. Recent advances in lung ultrasound (LUS) technology have made LUS-guided non-fiberobronchoscopic bronchoalveolar lavage (NFB-BAL) a promising solution. This approach addresses the limitations of conventional BAL in neonates by enabling accurate diagnosis, precise lesion localization, and dynamic procedural monitoring, hence reducing complications. Based on international expert consensus, these guidelines were developed to improve knowledge and promote the application of this technology and enhance operational standardization to ensure its effectiveness and safety. These guidelines contain 17 recommendations on 13 key clinical issues for reference and implementation in clinical practice. The wide application of these guidelines is expected to help significantly improve the prognosis of critically ill newborns with atelectatic pulmonary diseases.
- 25 August 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (17) , 2712
Open AccessLung Ultrasound-Guided Non-Fiberobronchoscopic Bronchoalveolar Lavage for Neonatal Atelectatic Pulmonary Disease Treatment: Clinical Practice Guidelines Based on International Expert Consensus
Severe pulmonary diseases, including atelectasis, pneumonia, and meconium aspiration syndrome, are major causes of neonatal respiratory distress, weaning difficulties, ventilator or oxygen dependence, prolonged oxygen requirements, extended hospitalization, and poor prognosis. The lack of simple and effective treatment strategies seriously endangers the survival and health of newborns, particularly premature infants. Recent advances in lung ultrasound (LUS) technology have made LUS-guided non-fiberobronchoscopic bronchoalveolar lavage (NFB-BAL) a promising solution. This approach addresses the limitations of conventional BAL in neonates by enabling accurate diagnosis, precise lesion localization, and dynamic procedural monitoring, hence reducing complications. Based on international expert consensus, these guidelines were developed to improve knowledge and promote the application of this technology and enhance operational standardization to ensure its effectiveness and safety. These guidelines contain 17 recommendations on 13 key clinical issues for reference and implementation in clinical practice. The wide application of these guidelines is expected to help significantly improve the prognosis of critically ill newborns with atelectatic pulmonary diseases.
- Open Access
- 21 August 2026
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 14, 1905411
Hemodynamic profile of neonatal fungal sepsis with insights into the disease spectrum: a retrospective study
Background: Neonatal fungal sepsis is a significant contributor to late-onset sepsis in neonatal intensive care units, particularly among preterm and low-birth-weight infants. While its epidemiology and microbiology are well described, the hemodynamic profile remains poorly characterized. This study aimed to evaluate the clinical spectrum with a focused assessment of cardiovascular alterations using functional echocardiography. Methods: Data for this retrospective observational study were collected from a tertiary care neonatal intensive care unit over a three-year period. Neonates with culture-proven fungal sepsis were included. Demographic, clinical, microbiological and outcome data were analyzed. Functional echocardiography was performed during active infection and repeated after microbiological clearance according to unit protocol. Paired hemodynamic comparisons were performed among survivors. Results: Twenty-six neonates with fungal sepsis were included, of whom 73.1% were preterm and predominantly low birth weight. Non- Candida albicans species were the predominant isolates. Respiratory deterioration, feed intolerance and thrombocytopenia were common clinical manifestations, with frequent exposure to prolonged antibiotics, parenteral nutrition and central venous access. Functional echocardiography demonstrated significant cardiovascular involvement during active infection. Survivors showed reduced tricuspid annular plane systolic excursion (6.4 ± 1.2 vs. 7.8 ± 2.4 mm), elevated pulmonary artery systolic pressure (28.5 ± 17.3 vs. 12.8 ± 4.2 mmHg), and increased right ventricular output (315.0 ± 49.4 vs. 246.0 ± 27.1 mL/kg/min), suggesting right ventricular dysfunction with pulmonary vascular involvement and a hyperdynamic circulatory state. Diastolic dysfunction was reflected by lower tricuspid and mitral E/A ratios. Hemodynamic parameters improved following antifungal therapy and microbiological clearance, while left ventricular systolic function remained relatively preserved. Mortality was 19.2%. Conclusion: In this cohort, neonatal fungal sepsis was associated with reversible hemodynamic alterations, predominantly involving right ventricular function and the pulmonary circulation. Functional echocardiography may provide valuable physiological insights and assist targeted hemodynamic management. Although our study did not include a bacterial sepsis comparator cohort, the observed cardiovascular alterations are broadly consistent with those reported in published neonatal bacterial sepsis studies. Clinical trial registration: This study was registered with the Clinical Trials Registry of India (CTRI/2025/03/083270) on 23rd march 2025. Trial details are publicly accessible at https://ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=127824 .
- 21 August 2026
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 14, 1905411
Open AccessHemodynamic profile of neonatal fungal sepsis with insights into the disease spectrum: a retrospective study
Background: Neonatal fungal sepsis is a significant contributor to late-onset sepsis in neonatal intensive care units, particularly among preterm and low-birth-weight infants. While its epidemiology and microbiology are well described, the hemodynamic profile remains poorly characterized. This study aimed to evaluate the clinical spectrum with a focused assessment of cardiovascular alterations using functional echocardiography. Methods: Data for this retrospective observational study were collected from a tertiary care neonatal intensive care unit over a three-year period. Neonates with culture-proven fungal sepsis were included. Demographic, clinical, microbiological and outcome data were analyzed. Functional echocardiography was performed during active infection and repeated after microbiological clearance according to unit protocol. Paired hemodynamic comparisons were performed among survivors. Results: Twenty-six neonates with fungal sepsis were included, of whom 73.1% were preterm and predominantly low birth weight. Non- Candida albicans species were the predominant isolates. Respiratory deterioration, feed intolerance and thrombocytopenia were common clinical manifestations, with frequent exposure to prolonged antibiotics, parenteral nutrition and central venous access. Functional echocardiography demonstrated significant cardiovascular involvement during active infection. Survivors showed reduced tricuspid annular plane systolic excursion (6.4 ± 1.2 vs. 7.8 ± 2.4 mm), elevated pulmonary artery systolic pressure (28.5 ± 17.3 vs. 12.8 ± 4.2 mmHg), and increased right ventricular output (315.0 ± 49.4 vs. 246.0 ± 27.1 mL/kg/min), suggesting right ventricular dysfunction with pulmonary vascular involvement and a hyperdynamic circulatory state. Diastolic dysfunction was reflected by lower tricuspid and mitral E/A ratios. Hemodynamic parameters improved following antifungal therapy and microbiological clearance, while left ventricular systolic function remained relatively preserved. Mortality was 19.2%. Conclusion: In this cohort, neonatal fungal sepsis was associated with reversible hemodynamic alterations, predominantly involving right ventricular function and the pulmonary circulation. Functional echocardiography may provide valuable physiological insights and assist targeted hemodynamic management. Although our study did not include a bacterial sepsis comparator cohort, the observed cardiovascular alterations are broadly consistent with those reported in published neonatal bacterial sepsis studies. Clinical trial registration: This study was registered with the Clinical Trials Registry of India (CTRI/2025/03/083270) on 23rd march 2025. Trial details are publicly accessible at https://ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=127824 .
- Open Access
- 12 June 2026
- Published by Springer Nature in BMC Pediatrics
“Hemodynamic effects of nasal intermittent positive pressure ventilation versus nasal continuous positive airway pressure in preterm neonates following extubation: a randomized controlled trial”
Nasal continuous positive airway pressure (NCPAP) and nasal intermittent positive pressure ventilation (NIPPV) are two commonly used modalities of non-inva
- 12 June 2026
- Published by Springer Nature in BMC Pediatrics
Open Access“Hemodynamic effects of nasal intermittent positive pressure ventilation versus nasal continuous positive airway pressure in preterm neonates following extubation: a randomized controlled trial”
Nasal continuous positive airway pressure (NCPAP) and nasal intermittent positive pressure ventilation (NIPPV) are two commonly used modalities of non-inva
- Open Access
- 31 March 2026
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 14, 1746228
Management of patent ductus arteriosus in preterm neonates ≤32 weeks: a national survey of physician practices in Indian NICUs
Introduction: Patent Ductus Arteriosus is very common in preterm neonates ≤ 32 weeks gestation, and practice variations, particularly in high-income countries have been reported, with minimal reports from LMIC countries like India. We aim to determine the current physician practices prevalent in the management of preterm PDA in neonates ≤ 32 weeks, in India. Methods: This 25-question survey was sent to physicians working in in Level III, II, and I NICUs in India. Results: 238 neonatal physicians responded to the survey (response rate 57.8%), revealing that 81.5% worked in Level III units. 60% respondents had access to an echo machine in the NICU, while 13.9% did not have an echo machine in their units. 39.9% physicians reported being formally trained in neonatal echocardiography/proficient through experience, whereas 20.2% did not perform neonatal echocardiography. 40.7% respondents reported that echocardiography was performed by adult/ paediatric cardiologists. 62.2% preferred an ‘early-symptomatic treatment' strategy, while 29.4% favoured an ‘early-targeted treatment’ approach for ELBW neonates. Paracetamol was the first-line drug choice for 80% respondents (intravenous preferred over oral), followed by oral Ibuprofen (16.4%). 57.6% clinicians repeated the same drug for the second course when needed, and a similar number performed an echo-reassessment after completion of the full treatment course. 68.9% attempted medical closure up to two times, whereas access to surgical closure was limited for 70.5% of physicians. Conclusions: Access to echocardiography machines has improved in the last few years in India, though, even now, less than half of our neonatal physicians are appropriately trained in performing neonatal echocardiography. Physicians prefer an ‘early symptomatic treatment’ strategy and use Paracetamol as the first-line management, which differs from international practices. Access to surgical options in Indian NICUs is limited. Though management approaches are similar among physicians, critical areas such as echo availability, access to advanced echo training, and surgical (device) closure of PDA still need improvement to ensure equitable and optimal care for neonates with HsPDA.
- 31 March 2026
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 14, 1746228
Open AccessManagement of patent ductus arteriosus in preterm neonates ≤32 weeks: a national survey of physician practices in Indian NICUs
Introduction: Patent Ductus Arteriosus is very common in preterm neonates ≤ 32 weeks gestation, and practice variations, particularly in high-income countries have been reported, with minimal reports from LMIC countries like India. We aim to determine the current physician practices prevalent in the management of preterm PDA in neonates ≤ 32 weeks, in India. Methods: This 25-question survey was sent to physicians working in in Level III, II, and I NICUs in India. Results: 238 neonatal physicians responded to the survey (response rate 57.8%), revealing that 81.5% worked in Level III units. 60% respondents had access to an echo machine in the NICU, while 13.9% did not have an echo machine in their units. 39.9% physicians reported being formally trained in neonatal echocardiography/proficient through experience, whereas 20.2% did not perform neonatal echocardiography. 40.7% respondents reported that echocardiography was performed by adult/ paediatric cardiologists. 62.2% preferred an ‘early-symptomatic treatment' strategy, while 29.4% favoured an ‘early-targeted treatment’ approach for ELBW neonates. Paracetamol was the first-line drug choice for 80% respondents (intravenous preferred over oral), followed by oral Ibuprofen (16.4%). 57.6% clinicians repeated the same drug for the second course when needed, and a similar number performed an echo-reassessment after completion of the full treatment course. 68.9% attempted medical closure up to two times, whereas access to surgical closure was limited for 70.5% of physicians. Conclusions: Access to echocardiography machines has improved in the last few years in India, though, even now, less than half of our neonatal physicians are appropriately trained in performing neonatal echocardiography. Physicians prefer an ‘early symptomatic treatment’ strategy and use Paracetamol as the first-line management, which differs from international practices. Access to surgical options in Indian NICUs is limited. Though management approaches are similar among physicians, critical areas such as echo availability, access to advanced echo training, and surgical (device) closure of PDA still need improvement to ensure equitable and optimal care for neonates with HsPDA.
- Open Access
- 7 October 2025
- Published by BMJ in BMJ Paediatrics Open
- Vol. 9 (1) , e003851
Improving neonatal total parenteral nutrition (TPN) safety and standardisation in a tertiary NICU: a multicomponent QI initiative
Introduction: Total parenteral nutrition (TPN) is essential for newborns admitted to the neonatal intensive care unit (NICU) who are unable to meet their nutritional requirements through enteral feeding. However, practices often vary due to resource constraints, lack of standardisation and inadequate training—leading to contamination risks, suboptimal nutrition and increased infections. At our 60-bed tertiary NICU (≈1500 admissions/year), adherence to TPN standards was only 10%. This quality improvement project aimed to increase adherence to >80% through a structured, multidisciplinary protocol. Methods: A stepwise quality improvement initiative using planning, implementation, evaluation and action cycles was implemented. Interventions included shifting TPN preparation to trained residents, introducing a laminar flow surveillance system, deploying an Excel-based TPN calculator, modifying TPN composition to reduce contamination and establishing a rotation schedule. Ongoing training, competency checks and real-time monitoring were incorporated to support sustainability. Results: Adherence to standardised TPN practices improved from a baseline of ~10% to sustained levels, with an overall mean adherence of 84.2% . The Statistical Process Control (SPC) analysis demonstrated a centreline shift from 66.0% in the early unstable phase to 94.1% in the stable phase, confirming sustained process improvement. As a balancing outcome, the overall sepsis incidence among inborn neonates on TPN was 3.2%. Conclusion: This quality improvement initiative successfully enhanced adherence to standardised TPN protocols in the NICU through structured training, workflow optimisation and process surveillance. The structured, practical and team-based approach offers a scalable model for improving the quality and consistency of TPN practices in resource-limited settings, with sustained monitoring and regular training remaining essential for long-term success.
- 7 October 2025
- Published by BMJ in BMJ Paediatrics Open
- Vol. 9 (1) , e003851
Open AccessImproving neonatal total parenteral nutrition (TPN) safety and standardisation in a tertiary NICU: a multicomponent QI initiative
Introduction: Total parenteral nutrition (TPN) is essential for newborns admitted to the neonatal intensive care unit (NICU) who are unable to meet their nutritional requirements through enteral feeding. However, practices often vary due to resource constraints, lack of standardisation and inadequate training—leading to contamination risks, suboptimal nutrition and increased infections. At our 60-bed tertiary NICU (≈1500 admissions/year), adherence to TPN standards was only 10%. This quality improvement project aimed to increase adherence to >80% through a structured, multidisciplinary protocol. Methods: A stepwise quality improvement initiative using planning, implementation, evaluation and action cycles was implemented. Interventions included shifting TPN preparation to trained residents, introducing a laminar flow surveillance system, deploying an Excel-based TPN calculator, modifying TPN composition to reduce contamination and establishing a rotation schedule. Ongoing training, competency checks and real-time monitoring were incorporated to support sustainability. Results: Adherence to standardised TPN practices improved from a baseline of ~10% to sustained levels, with an overall mean adherence of 84.2% . The Statistical Process Control (SPC) analysis demonstrated a centreline shift from 66.0% in the early unstable phase to 94.1% in the stable phase, confirming sustained process improvement. As a balancing outcome, the overall sepsis incidence among inborn neonates on TPN was 3.2%. Conclusion: This quality improvement initiative successfully enhanced adherence to standardised TPN protocols in the NICU through structured training, workflow optimisation and process surveillance. The structured, practical and team-based approach offers a scalable model for improving the quality and consistency of TPN practices in resource-limited settings, with sustained monitoring and regular training remaining essential for long-term success.
- Open Access
- 29 August 2025
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 13, 1632908
Utility of point-of-care ultrasound of the liver in the neonatal intensive care unit: experience from a case series
Introduction: Point-of-care ultrasound (POCUS) is increasingly being utilized for the management of sick and premature neonates in the neonatal intensive care unit (NICU). While neonatologist-performed cranial, lung, and cardiac ultrasound have become the standard of care in many NICUs across the world, the use of POCUS for the evaluation of the liver remains relatively unexplored.Materials and methods: This case series included neonates admitted to a tertiary-care NICU between January 2021 and April 2025, with radiological liver abnormalities detected on point-of-care ultrasound by treating neonatal physicians. Cases were identified from stored ultrasound images, and clinical data were extracted from electronic and physical medical records.Results: Six patients were identified, in whom a liver POCUS performed by the treating physician revealed a radiological liver abnormality for presenting symptoms that did not include cholestasis or deranged liver function tests. The conditions diagnosed included liver hemangioma, total anomalous pulmonary venous connection, liver hematoma, hepatic abscess, hepatic total parenteral nutrition extravasation, and portal vein thrombosis.Conclusion: This case series demonstrates the significant role of liver POCUS for the diagnosis of various conditions in neonates, which may be hematological, cardiac, infectious, hemorrhagic, or iatrogenic in origin. Incorporation of liver POCUS into NICU protocols for screening symptomatic infants, particularly those with umbilical venous catheters, pulmonary hypertension, congestive cardiac failure, or unexplained deterioration, may expedite early diagnosis and management of such conditions.
- 29 August 2025
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 13, 1632908
Open AccessUtility of point-of-care ultrasound of the liver in the neonatal intensive care unit: experience from a case series
Introduction: Point-of-care ultrasound (POCUS) is increasingly being utilized for the management of sick and premature neonates in the neonatal intensive care unit (NICU). While neonatologist-performed cranial, lung, and cardiac ultrasound have become the standard of care in many NICUs across the world, the use of POCUS for the evaluation of the liver remains relatively unexplored.Materials and methods: This case series included neonates admitted to a tertiary-care NICU between January 2021 and April 2025, with radiological liver abnormalities detected on point-of-care ultrasound by treating neonatal physicians. Cases were identified from stored ultrasound images, and clinical data were extracted from electronic and physical medical records.Results: Six patients were identified, in whom a liver POCUS performed by the treating physician revealed a radiological liver abnormality for presenting symptoms that did not include cholestasis or deranged liver function tests. The conditions diagnosed included liver hemangioma, total anomalous pulmonary venous connection, liver hematoma, hepatic abscess, hepatic total parenteral nutrition extravasation, and portal vein thrombosis.Conclusion: This case series demonstrates the significant role of liver POCUS for the diagnosis of various conditions in neonates, which may be hematological, cardiac, infectious, hemorrhagic, or iatrogenic in origin. Incorporation of liver POCUS into NICU protocols for screening symptomatic infants, particularly those with umbilical venous catheters, pulmonary hypertension, congestive cardiac failure, or unexplained deterioration, may expedite early diagnosis and management of such conditions.
- Open Access
- 22 July 2025
- Published by Springer Nature in Cureus
- Vol. 17 (7)
Robertmurraya beringensis Causing Late-Onset Sepsis in Neonates: A Case Series of a Hitherto Unreported Organism
Late-onset sepsis is an important cause of mortality and morbidity in neonates. Gram-positive organisms are increasingly being recognized as causing clinically significant sepsis. Bacillus beringensis was first reported as a novel species of the genus Bacillus and has not been reported to cause clinically significant infections in humans. This organism was reclassified as Robertmurraya beringensis in 2020, following taxonomic changes. We report six neonates, all of whom developed sepsis with this organism. In our patients, the organism was identified with matrix-assisted laser desorption ionization time-of-flight mass spectroscopy (MALDI-TOF-MS) test and revealed a mild-to-moderate virulence pattern. The neonates had predominantly gastrointestinal symptoms, with blood culture positivity in five neonates, and one neonate had the organism in the cerebrospinal fluid. The clinical outcomes were favorable in all the neonates, but one neonate died due to unrelated complications. With the significant emergence of multidrug-resistant organisms and the increasing survival of smaller neonates, this organism may become more significant as a causative agent in NICUs.
- 22 July 2025
- Published by Springer Nature in Cureus
- Vol. 17 (7)
Open AccessRobertmurraya beringensis Causing Late-Onset Sepsis in Neonates: A Case Series of a Hitherto Unreported Organism
Late-onset sepsis is an important cause of mortality and morbidity in neonates. Gram-positive organisms are increasingly being recognized as causing clinically significant sepsis. Bacillus beringensis was first reported as a novel species of the genus Bacillus and has not been reported to cause clinically significant infections in humans. This organism was reclassified as Robertmurraya beringensis in 2020, following taxonomic changes. We report six neonates, all of whom developed sepsis with this organism. In our patients, the organism was identified with matrix-assisted laser desorption ionization time-of-flight mass spectroscopy (MALDI-TOF-MS) test and revealed a mild-to-moderate virulence pattern. The neonates had predominantly gastrointestinal symptoms, with blood culture positivity in five neonates, and one neonate had the organism in the cerebrospinal fluid. The clinical outcomes were favorable in all the neonates, but one neonate died due to unrelated complications. With the significant emergence of multidrug-resistant organisms and the increasing survival of smaller neonates, this organism may become more significant as a causative agent in NICUs.
- 24 February 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (2) , e264598
Antenatal diagnosis and early postnatal management of a neonate with type 1 familial glucocorticoid deficiency
Familial glucocorticoid deficiency (FGD) is a rare inherited cause of primary adrenal insufficiency, characterised by cortisol deficiency, without mineralocorticoid involvement. Affected patients commonly present in infancy or early childhood with hypoglycaemia, seizures, generalised hyperpigmentation and failure to thrive. Late diagnosis may lead to adverse neurological outcomes, usually resulting from repeated hypoglycaemic episodes. A family history of sibling deaths or affected relatives is often observed. Mutations in the gene encoding adrenocorticotropin receptor (melanocortin 2 receptor, MC2R), comprise about 25% of FGD cases (type 1 FGD). Here, we describe an infant born to parents with third-degree consanguinity and a history of unexplained neonatal deaths in two previous siblings, who had hyperpigmentation and hypoglycaemia. Genetic testing revealed both parents to be heterozygous for the MC2R gene variant c.701C>C/T (p.Pro234Leu). In the current pregnancy, amniocentesis performed for prenatal diagnosis confirmed the fetus to be homozygous for the same mutation as the parents, indicating the fetus would be affected with type I FGD. After birth, the infant was managed in the neonatal intensive care unit, and despite markedly low cortisol levels, prompt initiation of glucocorticoid replacement therapy resulted in the prevention of hypoglycaemia and adrenal crisis, with a favourable outcome. Our case is unique due to the antenatal diagnosis of FGD, allowing for proactive postnatal management and prevention of complications.
- 24 February 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (2) , e264598
Antenatal diagnosis and early postnatal management of a neonate with type 1 familial glucocorticoid deficiency
Familial glucocorticoid deficiency (FGD) is a rare inherited cause of primary adrenal insufficiency, characterised by cortisol deficiency, without mineralocorticoid involvement. Affected patients commonly present in infancy or early childhood with hypoglycaemia, seizures, generalised hyperpigmentation and failure to thrive. Late diagnosis may lead to adverse neurological outcomes, usually resulting from repeated hypoglycaemic episodes. A family history of sibling deaths or affected relatives is often observed. Mutations in the gene encoding adrenocorticotropin receptor (melanocortin 2 receptor, MC2R), comprise about 25% of FGD cases (type 1 FGD). Here, we describe an infant born to parents with third-degree consanguinity and a history of unexplained neonatal deaths in two previous siblings, who had hyperpigmentation and hypoglycaemia. Genetic testing revealed both parents to be heterozygous for the MC2R gene variant c.701C>C/T (p.Pro234Leu). In the current pregnancy, amniocentesis performed for prenatal diagnosis confirmed the fetus to be homozygous for the same mutation as the parents, indicating the fetus would be affected with type I FGD. After birth, the infant was managed in the neonatal intensive care unit, and despite markedly low cortisol levels, prompt initiation of glucocorticoid replacement therapy resulted in the prevention of hypoglycaemia and adrenal crisis, with a favourable outcome. Our case is unique due to the antenatal diagnosis of FGD, allowing for proactive postnatal management and prevention of complications.